Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity.

Hamid MHBA. et al, (2024), Nat Immunol

Clinical identification of malignant pleural effusions.

Jia J. et al, (2023), Translational oncology, 39

Early Video Assisted Thoracoscopic Surgery (VATS) or Intrapleural Enzyme Therapy (IET) in Pleural Infection - A Feasibility Randomized Controlled Trial (The Third Multicenter Intrapleural Sepsis Trial - MIST-3).

Bedawi EO. et al, (2023), American journal of respiratory and critical care medicine

Achieving Molecular Profiling in Pleural Biopsies

Sundaralingam A. et al, (2023), Chest, 163, 1328 - 1339

Reply to Yasuma et al.

Bedawi EO. et al, (2023), American Journal of Respiratory and Critical Care Medicine, 207, 950 - 950

Editorial: Reviews in thoracic oncology

Kanellakis NI., (2023), Frontiers in Oncology, 13

The Biological Role of Pleural Fluid PAI-1 and Sonographic Septations in Pleural Infection: Analysis of a Prospectively Collected Clinical Outcome Study

Bedawi EO. et al, (2022), American Journal of Respiratory and Critical Care Medicine

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

Evans RA. et al, (2022), The Lancet Respiratory Medicine, 10, 761 - 775

The bacteriology of pleural infection (TORPIDS): an exploratory metagenomics analysis through next generation sequencing

Kanellakis NI. et al, (2022), The Lancet Microbe, 3, e294 - e302

Malignant pleural effusion: Updates in diagnosis, management and current challenges.

Addala DN. et al, (2022), Frontiers in oncology, 12

Objective Thoracoscopic Criteria in Differentiation between Benign and Malignant Pleural Effusions

Ellayeh M. et al, (2022), Respiration, 101, 46 - 56

INDWELLING PLEURAL CATHETER REMOVAL AND AUTO-PLEURODESIS: PREDICTORS AND OUTCOME

Addala DN. et al, (2021), THORAX, 76, A160 - A161

PAI-1 IS THE PREDOMINANT BIOLOGICAL FACTOR ASSOCIATED WITH SEPTATION FORMATION IN PLEURAL INFECTION

Bedawi EO. et al, (2021), THORAX, 76, A12 - A12

The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma

Asciak R. et al, (2021), Chest, 160, 1925 - 1933

THE BIOCHEMISTRY OF 'NON-SPECIFIC PLEURITIS'

Sundaralingam A. et al, (2021), THORAX, 76, A171 - A171

Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion

Ellayeh M. et al, (2021), EUROPEAN RESPIRATORY JOURNAL, 58

Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation

Asciak R. et al, (2021), Frontiers in Oncology, 11

THORACOSCOPIC EVALUATION OF THE EFFECT OF TUMOUR BURDEN ON THE OUTCOME OF PLEURODESIS IN MALIGNANT PLEURAL EFFUSION

Ellayeh MA. et al, (2021), THORAX, 76, A201 - A201

Evaluation of cardiovascular risk in a lung cancer screening cohort: What value does it bring?

Guariglia A. et al, (2020), Breathe, 16, 1 - 4

Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments

Kanellakis NI. et al, (2020), Thorax, 75, 1004 - 1008

Load More

Include forthcoming?